companyName

feedTypes

includeDividend

includeEstimates

includeExtensive

includeOverview

includeOwnership

includeShortSelling

researchId

CompanyPage_Query

companySlug

CompanyMetaData

Company_query

company

name

description

pageUrl

websiteUrl

logoUrl

squareLogoUrl

defaultInstrument

companyInsref

viewerIsFollowing

followersCount

isCorporateCustomer

hasVaraConsensus

hasDividendHistory

sector

regions

extensiveResearchExists

hasPinpointData

topOwners

insiderTransactions

varaConsensus

isPayingCustomerOf

isFormerCustomerOf

feedContent

BrainCool

BrainCool appoints Anna Lindström as new CEO

BrainCool receives supplementary EU grant of approximately SEK 6 million for the COTTIS 2 study and strengthens its clinical team

BrainCool publishes information document regarding rights issue

Communiqué from extraordinary general meeting in BrainCool

NOTICE OF EXTRA GENERAL MEETING IN BRAINCOOL AB (PUBL)

BrainCool carries out a rights issue of approximately SEK 42 million which is fully covered by subscription undertakings and advances publication of Q3 report

BrainCool AB (publ) - Financial Report for Q2 2025

ZOLL® orders custom-built IQool Tabletops to accelerate sales

BrainCool receives an order for 10 demo versions of BrainCool™ System from ZOLL®

BrainCool receives orders for consumable products to a value of SEK 8 million

BrainCool AB (publ) - Year End Report 2024

BrainCool receives market approval for BrainCool™ System in Malaysia

Karolinska expands PRINCESS 2 with BrainCool's product RhinoChill® System to additional countries, first patient outside of Sweden included

BrainCool AB (publ) adds two centers to the COTTIS 2 clinical study of its cooling systems in stroke patients

BrainCool appoints Jens Lindberg as new Chairman of the Board

BrainCool AB (publ) - Financial Report for Q3 2024

BrainCool AB (publ) cancels the loan agreement with EIB, as it is no longer appropriate for the company

BrainCool AB (publ) - Financial Report for Q2 2024

BrainCool AB (publ) – the first patient has been treated with RhinoChill® System in the pivotal COTTIS 2 study

BrainCool AB (publ) – the first patient can now be enrolled in the pivotal COTTIS 2 study

Braincool AB (publ): Bulletin from the annual general meeting

BioStock: BrainCool's new CEO on his visions for the company

Notice of annual general meeting in BrainCool AB (publ)

BrainCool AB (publ) announces final outcome in over-subscribed rights issue, corresponding to previously announced preliminary outcome

BrainCool AB (publ) announces preliminary outcome in over-subscribed rights issue

First North Stockholm

BrainCool operates in the medical technology sector. The company develops products for medical cooling of the brain. The technology is developed as cooling pads that are applied to different parts of the patient's body, where the system controls body temperature. The products are used in the treatment of various serious conditions including stroke, cardiac arrest, as well as concussion and migraine. BrainCool was founded in 2010 and is headquartered in Lund.

Anders Hallberg

Avanza Pension

Yksityisyysasetukset

BrainCool

Sijoittajien näkemys

Sijoittajien ennusteet

BrainCool

Sijoittajien näkemys

Sijoittajien ennusteet